ID1 and cancer: Besides, treatment of Id1-overexpressing NSCLC cells with paclitaxel and cisplatin led to a reduced level of phosphorylated Akt at Ser473 (Figure 1E), which was known a downstream signaling molecule of Id1 in NSCLC and other cancer cells [15, 44].